Search

Cephia D Toomer

Examiner (ID: 3411, Phone: (571)272-1126 , Office: P/1771 )

Most Active Art Unit
1771
Art Unit(s)
1771, 1721, 1111, 1714, 1797
Total Applications
2889
Issued Applications
1862
Pending Applications
318
Abandoned Applications
709
Applications
StatisticsSubscription-Only

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3111917 [patent_doc_number] => 05464778 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-07 [patent_title] => 'Glycoprotein ligand for P-selectin and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/278551 [patent_app_country] => US [patent_app_date] => 1994-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12185 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/464/05464778.pdf [firstpage_image] =>[orig_patent_app_number] => 278551 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/278551 		Glycoprotein ligand for P-selectin and methods of use thereof Jul 20, 1994 Issued
08/157128 PHARMACEUTICAL COMPOSITIONS Dec 5, 1993 Abandoned
Array ( [id] => 3007055 [patent_doc_number] => 05374711 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-20 [patent_title] => 'Chemical modification of 2\"-amino group in elsamicin a' [patent_app_type] => 1 [patent_app_number] => 8/122347 [patent_app_country] => US [patent_app_date] => 1993-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4732 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/374/05374711.pdf [firstpage_image] =>[orig_patent_app_number] => 122347 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/122347 		Chemical modification of 2"-amino group in elsamicin a Sep 14, 1993 Issued
Array ( [id] => 3567088 [patent_doc_number] => 05484775 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-16 [patent_title] => 'Semisynthetic ganglioside analogues' [patent_app_type] => 1 [patent_app_number] => 8/096853 [patent_app_country] => US [patent_app_date] => 1993-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22084 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/484/05484775.pdf [firstpage_image] =>[orig_patent_app_number] => 096853 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/096853 		Semisynthetic ganglioside analogues Jul 25, 1993 Issued
08/096745 METHOD FOR PRECIPITATING NATURAL AVERMECTINS Jul 22, 1993 Pending
08/095657 BIVALENT SIALYL LEWIS X SACCHARIDES Jul 20, 1993 Pending
08/086456 SACCHARIDE FOR SUPPLEMENTING ENERGY TO LIVING BODY, AND USES Jul 5, 1993 Pending
08/079544 PLASMALOPSYCHOSINES AND PLASMALOCEREBROSIDES AND METHODS OF TREATING NEURONAL DISEASES EMPLOYING THE SAME Jun 21, 1993 Pending
08/062957 SELECTIN RECEPTOR MODULATING COMPOSITIONS May 13, 1993 Pending
08/035689 2'-DEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AND ANTICANCER AGENTS Mar 22, 1993 Pending
Array ( [id] => 3425502 [patent_doc_number] => 05422343 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-06 [patent_title] => 'Prophylactic and therapeutic composition for MRSA infection' [patent_app_type] => 1 [patent_app_number] => 8/026744 [patent_app_country] => US [patent_app_date] => 1993-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5581 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/422/05422343.pdf [firstpage_image] =>[orig_patent_app_number] => 026744 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/026744 		Prophylactic and therapeutic composition for MRSA infection Mar 4, 1993 Issued
08/009110 CYCLIC AMP DERIVATIVE-CONTAINING OINTMENT Jan 25, 1993 Abandoned
07/993901 ELABORATION OF HOST DEFENSE MEDIATORS INTO BIOLOGICAL FLUIDS BY SYSTEMIC DSRNA TREATMENT Dec 17, 1992 Abandoned
07/989719 PYRIMIDINE NUCLEOSIDE DERIVATIVES Dec 13, 1992 Abandoned
07/988518 TIME DEPENDENT ADMINISTRATION OF OLIGOSACCHARIDE GLYCOSIDES RELATED TO BLOOD GROUP DETERMINANTS HAVING A TYPE I OR TYPE II CORE STRUCTURE IN REDUCING INFLAMMATION IN A SENSITIZED MAMMAL ARISING FROM EXPOSURE TO AN ANTIGEN Dec 9, 1992 Abandoned
07/976552 GLYCOPROTEIN LIGAND FOR P-SELECTIN AND METHODS OF USE THEREOF Nov 15, 1992 Abandoned
Array ( [id] => 2933913 [patent_doc_number] => 05229371 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-07-20 [patent_title] => 'Chemical modification of elsamicin A at the 3\' and/or 4\' OH groups' [patent_app_type] => 1 [patent_app_number] => 7/974376 [patent_app_country] => US [patent_app_date] => 1992-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4937 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/229/05229371.pdf [firstpage_image] =>[orig_patent_app_number] => 974376 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/974376 		Chemical modification of elsamicin A at the 3' and/or 4' OH groups Nov 9, 1992 Issued
07/946482 ANTITUMOR SUBSTANCE BE-13793C DERIVATIVES Nov 9, 1992 Abandoned
07/974750 COMPOSITIONS FOR THE REGULATION OF CYTOKINE ACTIVITY Nov 9, 1992 Abandoned
07/972073 CHEMICAL MODIFICATION OF 2"-AMINO GROUP IN ELSAMICIN A Nov 4, 1992 Abandoned
Menu